Literature DB >> 19016712

GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma.

Inga Vater1, Florian Wagner, Markus Kreuz, Hilmar Berger, José I Martín-Subero, Christiane Pott, Jose A Martinez-Climent, Wolfram Klapper, Kristina Krause, Martin J S Dyer, Stefan Gesk, Lana Harder, Alberto Zamo, Martin Dreyling, Dirk Hasenclever, Norbert Arnold, Reiner Siebert.   

Abstract

The translocation t(11;14)(q13;q32) is the genetic hallmark of mantle cell lymphoma (MCL) but is not sufficient for inducing lymphomagenesis. Here we performed genome-wide 100K GeneChip Mapping in 26 t(11;14)-positive MCL and six MCL cell lines. Partial uniparental disomy (pUPD) was shown to be a recurrent chromosomal event not only in MCL cell lines but also in primary MCL. Remarkably, pUPD affected recurrent targets of deletion like 11q, 13q and 17p. Moreover, we identified 12 novel regions of recurrent gain and loss as well as 12 high-level amplifications and eight homozygously deleted regions hitherto undescribed in MCL. Interestingly, GeneChip analyses identified different genes, encoding proteins involved in microtubule dynamics, such as MAP2, MAP6 and TP53, as targets for chromosomal aberration in MCL. Further investigation, including mutation analyses, fluorescence in situ hybridisation as well as epigenetic and expression studies, revealed additional aberrations frequently affecting these genes. In total, 19 of 20 MCL cases, which were subjected to genetic and epigenetic analyses, and five of six MCL cell lines harboured at least one aberration in MAP2, MAP6 or TP53. These findings provide evidence that alterations of microtubule dynamics might be one of the critical events in MCL lymphomagenesis contributing to chromosomal instability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19016712     DOI: 10.1111/j.1365-2141.2008.07443.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

Authors:  Javeed Iqbal; Yulei Shen; Yanyan Liu; Kai Fu; Elaine S Jaffe; Cuiling Liu; Zhongfeng Liu; Cynthia M Lachel; Karen Deffenbacher; Timothy C Greiner; Julie M Vose; Sharathkumar Bhagavathi; Louis M Staudt; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

Review 2.  Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era.

Authors:  Patricia Pérez-Galán; Martin Dreyling; Adrian Wiestner
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

3.  Interleukin 22 signaling promotes cell growth in mantle cell lymphoma.

Authors:  Pascal Gelebart; Zoulika Zak; Jennifer Dien-Bard; Mona Anand; Raymond Lai
Journal:  Transl Oncol       Date:  2011-02-01       Impact factor: 4.243

4.  Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.

Authors:  Elena M Hartmann; Elias Campo; George Wright; Georg Lenz; Itziar Salaverria; Pedro Jares; Wenming Xiao; Rita M Braziel; Lisa M Rimsza; Wing-Chung Chan; Dennis D Weisenburger; Jan Delabie; Elaine S Jaffe; Randy D Gascoyne; Sandeep S Dave; Hans-Konrad Mueller-Hermelink; Louis M Staudt; German Ott; Sílvia Beà; Andreas Rosenwald
Journal:  Blood       Date:  2010-04-26       Impact factor: 22.113

5.  Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis.

Authors:  René Scholtysik; Markus Kreuz; Wolfram Klapper; Birgit Burkhardt; Alfred C Feller; Michael Hummel; Markus Loeffler; Maciej Rosolowski; Carsten Schwaenen; Rainer Spang; Harald Stein; Christoph Thorns; Lorenz Trümper; Inga Vater; Swen Wessendorf; Thorsten Zenz; Reiner Siebert; Ralf Küppers
Journal:  Haematologica       Date:  2010-09-07       Impact factor: 9.941

6.  Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1.

Authors:  Nityanand Maddodi; Kumar M R Bhat; Sulochana Devi; Su-Chun Zhang; Vijayasaradhi Setaluri
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

7.  Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling.

Authors:  Chiara Pighi; Ting-Lei Gu; Irene Dalai; Stefano Barbi; Claudia Parolini; Anna Bertolaso; Serena Pedron; Alice Parisi; Jianmin Ren; Daniela Cecconi; Marco Chilosi; Fabio Menestrina; Alberto Zamò
Journal:  Cell Oncol (Dordr)       Date:  2011-03-11       Impact factor: 6.730

8.  Investigation of Rho-Kinase Expressions and Polymorphisms in Mantle Cell Lymphoma Patients.

Authors:  Didar Yanardağ Açık; Mehmet Yılmaz; İbrahim Sarı; Serdar Öztuzcu; Zeynel A Sayıner; Salih Subari; Abdullah T Demiryürek
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

Review 9.  Microtubule-associated proteins (MAPs) in microtubule cytoskeletal dynamics and spermatogenesis.

Authors:  Lingling Wang; Ming Yan; Chris K C Wong; Renshan Ge; Xiaolong Wu; Fei Sun; C Yan Cheng
Journal:  Histol Histopathol       Date:  2020-11-11       Impact factor: 2.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.